Andrew Scott Blank, Director at BioCardia, Inc. (BCDA), bought 288,000 shares at $1.25 ($360K) on 2025-09-19, disclosed to the SEC on 2025-09-23.
Open-market purchase of $360k BCDA by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Clearly above the average filing.
| Filing → |
| BCDA | BUY | 2020-06-23 | $300K | — | Filing → |